To Any Expert with knowledge of Clinical Trial Analysis | IMGN Message Board Posts

ImmunoGen, Inc.

  IMGN website

IMGN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  49876 of 50108  at  9/20/2019 2:09:16 PM  by

Bibliobiftek

The following message was updated on 9/20/2019 2:10:07 PM.

 In response to msg 49875 by  erniewerner
view thread

Re: To Any Expert with knowledge of Clinical Trial Analysis

Good points; I agree that the OS results from F1 in this subgroup are by far the most promising data out of the publically released topline data. I would want to see some evidence that this OS signal is directly related to the characteristics of MS: perhaps it is related to the much lower toxicity of MS compared to chemo, and we'll probably see if this affected the duration patients were able to sustain therapy shortly. I believe that Anna B. hinted that they will have an updated OS readout for ESMO, and hopefully the OS signal is maintained. 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 294
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...